This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: University Health Network, Covidien LP. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kenji Sugata: Innovator in Immunology
Introduction
Kenji Sugata is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 3 patents, Sugata's work has had a notable impact on medical research and applications.
Latest Patents
Sugata's latest patents include "MHC Class II Molecules and Methods of Use Thereof" and "T Cell Receptors and Methods of Use Thereof." These inventions focus on advancing our understanding of immune responses and developing new therapeutic strategies.
Career Highlights
Throughout his career, Kenji Sugata has worked with reputable organizations such as Covidien LP and the University Health Network. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Naoto Hirano and Kayoko Saso. Their collaborative efforts have further enhanced the quality and impact of Sugata's work in immunology.
Conclusion
Kenji Sugata's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical research and applications.